The Centauri™ System

The Centauri™ System

The Centauri™ System

The Centauri™ System

The Centauri System is CE-marked and available in select EU countries.

It is not commercially available in the United States.
CardioFocus is the exclusive distributor of the Centauri System.

Overview

The CardioFocus Centauri™ PFA System is a cutting edge, open platform design that supports your current focal contact force catheter workflow, leveraging a custom monopolar waveform designed to achieve transmural lesions while eliminating microbubbles and muscle stimulation. Seamlessly integrating into your existing workflows, the Centauri System enables physicians to confidently deliver durable PFA lesions while enhancing procedural efficiency, safety, and patient outcomes.

System features include:

  • Three selectable monopolar PFA doses offered at 19, 22, and 25 Amps for lesion control

  • Impedance balanced energy delivery to ensure consistent, predictable transmural lesions

  • Current control algorithm ensures consistent energy output in all patients

  • Versatility through an open platform supporting three commercially available contact force catheters:

    • TactiCath Sensor Enabled™

    • THERMOCOOL SMARTTOUCH™

    • INTELLANAV STABLEPOINT™

Compatible Mapping Systems &
Ablation Catheters

EnSite™ / TactiCath™ SE

EnSite™ / TactiCath™ SE

EnSite™ / TactiCath™ SE

Carto® 3 / ThermoCool SmartTouch™

Carto® 3 / ThermoCool SmartTouch™

Carto® 3 / ThermoCool SmartTouch™

Rhythmia HDx™ / IntellaNav Stablepoint™

Rhythmia HDx™ / IntellaNav Stablepoint™

Rhythmia HDx™ / IntellaNav Stablepoint™

Custom monopolar waveform

The Centauri System utilizes the custom WAVE1 monopolar biphasic waveform to deliver transmural PFA lesions while effectively eliminating the potential for microbubbles and muscle stimulation.

Simulation of a 19A monopolar dose, data on file

In a monopolar configuration, an electric field is created at the catheter tip that is directed towards a remote dispersive electrode. As a result, monopolar devices achieve deeper lesions than equivalent bipolar configurations.

The six-pillar approach to PEF therapy

The six-pillar approach to PEF therapy for use in conventional intracardiac ablation procedures gives electrophysiologists a next generation ablation tool designed for the highest level of safety and efficacy.

Wave 1

The proprietary waveform CardioFocus has customized for use in conventional intracardiac ablation procedures balances full-thickness tissue ablation while limiting the effects on extracardiac structures.

Energy setting

The Centauri Constellation energy delivery scheme gives physicians control, allowing one of three doses to be used for varying tissue thickness.

Zero bubbles

The WAVE1 waveform was designed to significantly reduce microbubbles which may embolize to the brain. Centauri has been designed using WAVE1 energy for safe and effective delivery of PEF. Our goal is a safe and effective delivery of PEF with zero bubbles.

Monopolar

Centauri uses monopolar PEF delivery for lesion control.

Automatic impedance

Tissue impedance is patient specific and impacts lesion formation during PEF delivery. Centauri monitors this between every delivery and optimizes dosing parameters to ensure consistent predictable transmural lesions.

Current control

The Centauri current control algorithm ensures a consistent current output from the catheter in all patients ensuring predictable lesion size.

Clinical studies

Safety outcomes

Esophageal injuries

0%

Phrenic nerve injuries

0%

PV stenosis

0%

Incidence of microbubbles per avaluation on intracardiac echocardiagram during ablation

0%

Efficacy outcomes

Overall, 89% PV isolation at 3 months using Centauri System with three compatible commercially available cardiac ablation catheters

Eclipse-AF PV isolation rate at 3 months

Overall PV Isolation Durablity = 89%

84%

TACTICATH SE (n = 38)

STABLEPOINT (n = 57)

90%

THERMOCOOL ST (n = 63)

92%

84%

TACTICATH SE
(n = 38)

STABLEPOINT
(n = 57)

90%

THERMOCOOL ST
(n = 63)

92%

84%

TACTICATH SE (n = 38)

90%

STABLEPOINT (n = 57)

92%

THERMOCOOL ST (n = 63)

92% PV isolation at 3 months using the Centauri System with the Biosense Webster Thermocool Smarttouch™ ablation catheter

90% PV isolation at 3 months using the Centauri System with the Boston Scientific Intellanav Stablepoint™ ablation catheter

84% PV isolation at 3 months using the Centauri System with the Abbott TactiCath™ Contact Force Sensing Catheter, Sensor Enabled™

Anić A et al. Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: acute and 90-day invasive remapping results. Europace. 2023 Jun 2;25(6):euad147.

Centauri Live Case

Watch Dr. Anic at KBC Split in Croatia perform a focal PFA ablation using the Centauri System.

Centauri Live Case

Watch Dr. Atul Verma at Southlake Regional Health Centre in Newmarket, Ontario perform a focal PFA ablation using the Centauri System.

PFA: Bipolar vs Monopolar Energy Delivery

Learn the clinical benefits and limitations of bipolar and monopolar energy deliver with pulsed field ablation

Ready to learn more?

Experience the future of cardiac care with CardioFocus: revolutionizing atrial fibrillation treatment with precision and efficiency

Ready to learn more?

Experience the future of cardiac care with CardioFocus: revolutionizing atrial fibrillation treatment with precision and efficiency

Ready to learn more?

Experience the future of cardiac care with CardioFocus: revolutionizing atrial fibrillation treatment with precision and efficiency

Ready to learn more?

Experience the future of cardiac care with CardioFocus: revolutionizing atrial fibrillation treatment with precision and efficiency

500 Nickerson Road
Marlborough, MA 01752

© CardioFocus. All rights reserved.

500 Nickerson Road
Marlborough, MA 01752

© CardioFocus. All rights reserved.

500 Nickerson Road
Marlborough, MA 01752

© CardioFocus. All rights reserved.

500 Nickerson Road
Marlborough, MA 01752

© CardioFocus. All rights reserved.